Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Effectiveness Analysis of Armeo Spring Device as a Rehabilitation Treatment in Spinal Cord Injured Patients

NCT04383873 · Hospital Nacional de Parapléjicos de Toledo · Updated 18 April 2022

What is being tested
Training by means of Armeo Spring device; Current treatment based on conventional therapy; Additional treatment based on conventional therapy
For
Spinal Cord Injury Cervical
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 16 years to 75 years. About 34 people. The full rules are on the registry page.
Where
Spain
When
Starts or started 18 June 2016, ends 28 Dec 2021. Registered 12 May 2020.
Results
None posted yet.

In the researchers' words

Loss of motor function is a consequence after a spinal cord injury (SCI). The incidence of SCI varies greatly from 12.1 to 57.8 cases per million depending on the country. More than 50% of people with SCI have impaired upper limb (UL) function, experiencing limitations in performing functional tasks. In this context, one of the rehabilitation objectives is to achieve the maximum level of independence in the patient in the performance of activities of daily living (ADL). Within the clinical setting, the main motivation in the use of robotic devices and/or exoskeletons for a rehabilitation purpose focuses on the fact that these help therapists in administering repetitive manual therapies to patients during exercises. There is evidence that the amount of therapy patients receive is insufficient. Without creating additional time demands on clinicians, robotic devices can perform the repetitive mechanical aspects of therapy, increasing the amount of therapy that patients receive. However, the current evidence in stroke patients suggests that the improvements observed are due to the intensity of the therapy, regardless of whether the administration of rehabilitation is due to robotic devices and/or traditional means. The main objective of this study is to analyze the effectiveness of the commercial Armeo® Spring system (Hocoma AG, Switzerland) and a Virtual Reality application to…
ClinicalTrials.gov, NCT04383873

Sites

  • Hospital Nacional de ParapléjicosToledo, Spain